Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis-Reference-Cited by-同舟云学术

Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis

Published:2020-12 Issue:4 Volume:19 Page:e151-e156
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Yaeger Rona,Paroder Viktoriya,Bates David D.B.,Capanu Marinela,Chou Joanne,Tang Laura,Chatila Walid^ORCID,Schultz Nikolaus,Hersch Jonathan,Kelsen David

Funder

Crohn’s and Colitis Foundation

Lostritto Family Foundation

James and Sigrid Mueller Fund

National Institutes of Health

National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference14 articles.

1. Prevalence of inflammatory bowel disease among adults aged ≥ 18 years—United States, 2015;Dahlhamer;MMWR Morb Mortal Wkly Rep,2016

2. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation;Itzkowitz;Am J Physiol Gastrointest Liver Physiol,2004

3. Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease;Yaeger;Gastroenterology,2016

4. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer;Yaeger;Cancer Cell,2018

5. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose dimethylfumarate attenuates colitis-associated cancer in mice through M2 macrophage polarization and blocking oxidative stress;Toxicology and Applied Pharmacology;2024-08

2. Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer;Biomedicine & Pharmacotherapy;2024-06

3. Pathology and Clinical Significance of Inflammatory Bowel Disease-Associated Colorectal Dysplastic Lesions;Gastroenterology Clinics of North America;2024-03

4. Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer;Frontiers in Oncology;2024-01-15

5. Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center;Digestive and Liver Disease;2023-09